Coronary Chronic Total Occlusions Represent an Independent Predictor of Mortality in Ventricular Tachyarrhythmias
EuroIntervention 2019; just accepted article published in January 2019. DOI: 10.4244/EIJ-D-18-00496
Michael Behnes1; Ibrahim Akin2; Philipp Kuche3; Tobias Schupp4; Linda Reiser5; Armin Bollow6; Gabriel Taton7; Thomas Reichelt8; Dominik Ellguth9; Niko Engelke10; Ibrahim El-Battrawy11; Siegfried Lang12; Emmanouil Brilakis13; Lorenzo Azzalini14; Alfredo R. Galassi15; Marouane Boukris16; Hans Neuser17; Franz-Joseph Neumann18; Christoph Nienaber19; Christel Weiß20; Martin Borggrefe21; Kambis Mashayekhi22;
1. Ruprecht Karls Universitat Heidelberg Medizinische Fakultat Mannheim, First Department of Medicine, University Medical Centre Mannheim, Mannheim, GERMANY; 2. First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, European Center for AngioScience (ECAS), and DZHK (German Center for Cardiovascular Research) partner site Heidelberg/Mannheim, Germany, GERMANY; 3. First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, European Center for AngioScience (ECAS), and DZHK (German Center for Cardiovascular Research) partner site Heidelberg/Mannheim.; 4. First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, European Center for AngioScience (ECAS), and DZHK (German Center for Cardiovascular Research) partner site Heidelberg/Mannheim.; 5. First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, European Center for AngioScience (ECAS), and DZHK (German Center for Cardiovascular Research) partner site Heidelberg/Mannheim.; 6. First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, European Center for AngioScience (ECAS), and DZHK (German Center for Cardiovascular Research) partner site Heidelberg/Mannheim.; 7. First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, European Center for AngioScience (ECAS), and DZHK (German Center for Cardiovascular Research) partner site Heidelberg/Mannheim.; 8. First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, European Center for AngioScience (ECAS), and DZHK (German Center for Cardiovascular Research) partner site Heidelberg/Mannheim.; 9. First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, European Center for AngioScience (ECAS), and DZHK (German Center for Cardiovascular Research) partner site Heidelberg/Mannheim.; 10. First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, European Center for AngioScience (ECAS), and DZHK (German Center for Cardiovascular Research) partner site Heidelberg/Mannheim.; 11. First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, European Center for AngioScience (ECAS), and DZHK (German Center for Cardiovascular Research) partner site Heidelberg/Mannheim.; 12. First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, European Center for AngioScience (ECAS), and DZHK (German Center for Cardiovascular Research) partner site Heidelberg/Mannheim.; 13. Minneapolis Heart Institute, Minneapolis, Minnesota, USA.; 14. Interventional Cardiology Unit, Cardio-Thoracic-Vascular Department, San Raffaele Scientific Institute, Milan, Italy.; 15. Department of Experimental and Clinical Medicine, University of Catania, Catania, Italy.; 16. Cardiology Department, Abderrhamen Mami Hospital, Ariana, Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.; 17. Helios Klinikum Plauen, Klinik für Innere Medizin II, Plauen, Germany.; 18. Department of Cardiology and Angiology II, University Heart Centre Freiburg, Bad Krozingen; 19. Royal Brompton and Harefield Hospitals, NHS, London, United Kingdom.; 20. Institute of Biomathematics and Medical Statistics, University Medical Center Mannheim (UMM), Faculty of Medicine Mannheim, Heidelberg University, Mannheim, Germany.; 21. First Department of Medicine, University Medical Centre Mannheim (UMM), Faculty of Medicine Mannheim, University of Heidelberg, European Center for AngioScience (ECAS), and DZHK (German Center for Cardiovascular Research) partner site Heidelberg/Mannheim.; 22. Department of Cardiology and Angiology II, University Heart Center Freiburg • Bad Krozingen, Bad Krozingen, Germany.
Disclaimer:
As a public service to our readership, this article - peer reviewed by the Editors of EuroIntervention -
has been published immediately upon acceptance as it was received. The content of this article is the sole
responsibility of the authors, and not that of the journal or its publishers.
To read the full content of this article, please log in to download the PDF.
Aims: This study sought to assess the prognostic impact of coronary chronic total occlusions (CTO) in patients presenting with ventricular tachyarrhythmias on admission.
Methods and results: A large retrospective registry was used including all consecutive patients presenting with ventricular tachyarrhythmias on admission and undergoing coronary angiography from 2002 to 2016. Patients with a CTO were compared with all other patients (non-CTO) for prognostic outcomes. Statistics comprised Kaplan Meier and Cox regression analyses.Within a total of 1,461 included consecutive patients with ventricular tachyarrhythmias on admission, a CTO was present in 20%. At mid-term follow-up of 18 months, the primary endpoint all-cause mortality had occurred in 46% of CTO patients compared to 27% of non-CTO patients (HR = 1.563; 95% CI 1.263 – 1.934; p=0.001). The rates of secondary endpoints were higher for in-hospital all-cause mortality at index (29% versus 20%, log rank p=0.027) and the composite endpoint of cardiac death at 24 hours, recurrent ventricular tachyarrhythmias and appropriate ICD therapies at mid-term follow-up (28% versus 20%; log rank p=0.005). Mortality rates were highest in CTO patients with stable CAD, acute myocardial infarction and in patients surviving index hospitalization.
Conclusions: In patients presenting with ventricular tachyarrhythmias on admission, the presence of a coronary CTO is independently associated with an increase of mid-term all-cause mortality, in hospital all-cause mortality and the composite endpoint of early cardiac death, recurrent ventricular tachyarrhythmias and appropriate ICD therapies.
